GNFT
Genfit S.A.
NASDAQ · Healthcare · Biotechnology · FR
$8.95
+4.07%Margins
Gross margin
104.9%
EBITDA margin
-1.2%
EBIT margin
0.4%
Net margin
-14.1%
FCF margin
-40.4%
-31.4%
Return on equity
-7.6%
Return on assets
0.3%
Return on invested capital
0.63x
Asset turnover
-$52.0M
Cash from operations
$2.51
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2025